• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.63 $0.02 (0.15%)

REAL-TIME: Last trade at

Anika Therapeutics, Inc.

NASDAQ:ANIK

Sunshine Ahead For This 'Organic' Shadow Stock

Zacks #5 Rank Additions for Friday - Tale of the Tape

Zacks #5 Rank Additions for Wednesday - Tale of the Tape

Zacks #5 Rank Additions for Thursday - Tale of the Tape

Zacks #5 Rank Additions for Thursday - Tale of the Tape

Zacks #5 Rank Additions for Tuesday - Tale of the Tape

Zacks #5 Rank Additions for Wednesday - Tale of the Tape

Zacks #5 Rank Additions for Friday - Tale of the Tape

Key Biotech Issues To Watch (XBI, ANIK, BCRX, CBST, DNDN, GILD, ILMN, TRGT)

Zacks #5 Rank Additions for Wednesday - Tale of the Tape

Zacks #5 Rank Additions for Monday - Tale of the Tape

Anika Therapeutics CEO Discusses Q2 2011 Results - Earnings Call Transcript

Anika Therapeutics' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Anika Therapeutics' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Anika Therapeutics Shares May Rebound

19 Micro Cap Stocks Being Dumped by Mutual Funds

Anika Therapeutics CEO Discusses Q4 2010 Results - Earnings Call Transcript

Anika Therapeutics CEO Discusses Q4 2010 Results - Earnings Call Transcript

Mid-Day Update: Stocks Down on Economic Data; Investors Eye NYSE, Deutsche Boerse Deal

Stocks Down at Mid-Day, But Off Lows, as Investors Digest Mixed Economic Data

Anika Therapeutics CEO Discusses Q3 2010 Results – Earnings Call Transcript

Anika Therapeutics CEO Discusses Q3 2010 Results – Earnings Call Transcript

Anika Therapeutics, Inc. Q2 2010 Earnings Call Transcript

Anika Therapeutics, Inc. Q2 2010 Earnings Call Transcript

UPDATE 1-Anika buys Italian firm's unit for $34 mln

HEADLINE STOCKS-U.S. small/midcap stocks on the move on Oct 28